CK2 and its role in Wnt and NF-κB signaling: Linking development and cancer

Cellular and Molecular Life Sciences

Volumn 66, Issue 11-12, 2009, Pages 1850-1857

  Dominguez, I ^a   Sonenshein, G E ^a   Seldin, D C ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Carcinogenesis; Casein kinase II; Development; Epithelial to mesenchymal transition; NF B; Protein kinase CK2; Wnt

Indexed keywords

CASEIN KINASE II; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; WNT PROTEIN;

ANIMAL; CELL TRANSFORMATION; EMBRYO DEVELOPMENT; HUMAN; METABOLISM; PHOSPHORYLATION; PHYSIOLOGY; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; CASEIN KINASE II; CELL TRANSFORMATION, NEOPLASTIC; EMBRYONIC DEVELOPMENT; HUMANS; NF-KAPPA B; PHOSPHORYLATION; SIGNAL TRANSDUCTION; WNT PROTEINS;

EID: 70349326247     PISSN: 1420682X     EISSN: 14209071     Source Type: Journal    
DOI: 10.1007/s00018-009-9153-z     Document Type: Review

References (66)

1. Miller, J. R. and Moon, R. T. (1996) Signal transduction through beta-catenin and specification of cell fate during embryogenesis. Genes Dev. 10, 2527-2539.
2. Giles, R. H., van Es, J. H. and Clevers, H. (2003) Caught up in a Wnt storm: Wnt signaling in cancer. Biochim. Biophys. Acta 1653, 1-24.
3. Cadigan, K. M. and Nusse, R. (1997) Wnt signaling: a common theme in animal development. Genes Dev. 11, 3286-3305.
4. Moon, R. T., Kohn, A. D., De Ferrari, G. V. and Kaykas, A. (2004) WNT and beta-catenin signalling: diseases and therapies. Nat. Rev. Genet. 5, 691-701.
5. Willert, K., Brink, M., Wodarz, A., Varmus, H. and Nusse, R. (1997) Casein kinase 2 associates with and phosphorylates dishevelled. EMBO J. 16, 3089-3096.
6. Song, D. H., Dominguez, I., Mizuno, J., Kaut, M., Mohr, S. C. and Seldin, D. C. (2003) CK2 phosphorylation of the armadillo repeat region of beta-catenin potentiates Wnt signaling. J. Biol. Chem. 278, 24018-24025.
7. Duyao, M. P., Kessler, D. J., Spicer, D. B., Bartholomew, C., Cleveland, J. L., Siekevitz, M. and Sonenshein, G. E. (1992) Transactivation of the c-myc promoter by human T cell leukemia virus type 1 tax is mediated by NF kappa B. J. Biol. Chem. 267, 16288-16291.
8. Sovak, M. A., Bellas, R. E., Kim, D. W., Zanieski, G. J., Rogers, A. E., Traish, A. M. and Sonenshein, G. E. (1997) Aberrant nuclear factor-kappaB/Rel expression and the pathogenesis of breast cancer. J. Clin. Invest. 100, 2952-2960.
9. Sonenshein, G. E. (1997) Rel/NF-kappa B transcription factors and the control of apoptosis. Semin. Cancer Biol. 8, 113-119.
10. Romieu-Mourez, R., Kim, D. W., Shin, S. M., Demicco, E. G., Landesman-Bollag, E., Seldin, D. C., Cardiff, R. D. and Sonenshein, G. E. (2003) Mouse mammary tumor virus c-rel transgenic mice develop mammary tumors. Mol. Cell. Biol. 23, 5738-5574.
11. Min, C., Eddy, S. F., Sherr, D. H. and Sonenshein, G. E. (2008) NF-kappaB and epithelial to mesenchymal transition of cancer. J. Cell. Biochem. 104, 733-744.
12. Wu, M., Min, C., Wang, X., Yu, Z., Kirsch, K. H., Trackman, P. C. and Sonenshein, G. E. (2007) Repression of BCL2 by the tumor suppressor activity of the lysyl oxidase propeptide inhibits transformed phenotype of lung and pancreatic cancer cells. Cancer Res. 67, 6278-6285.
13. Romieu-Mourez, R., Landesman-Bollag, E., Seldin, D. C. and Sonenshein, G. E. (2002) Protein kinase CK2 promotes aberrant activation of nuclear factor-kappaB, transformed phenotype, and survival of breast cancer cells. Cancer Res. 62, 6770-6778.
14. Romieu-Mourez, R., Landesman-Bollag, E., Seldin, D. C., Traish, A. M., Mercurio, F. and Sonenshein, G. E. (2001) Roles of IKK kinases and protein kinase CK2 in activation of nuclear factor-kappaB in breast cancer. Cancer Res. 61, 3810-3818.
15. Chu, Z. L., McKinsey, T. A., Liu, L., Qi, X. and Ballard, D. W. (1996) Basal phosphorylation of the PEST domain in the I(kappa)B(beta) regulates its functional interaction with the c-rel proto-oncogene product. Mol. Cell. Biol. 16, 5974-5984.
16. McElhinny, J. A., Trushin, S. A., Bren, G. D., Chester, N. and Paya, C. V. (1996) Casein kinase II phosphorylates I kappa B alpha at S-283, S-289, S-293, and T-291 and is required for its degradation. Mol. Cell. Biol. 16, 899-906.
17. Eddy, S. F., Guo, S., Demicco, E. G., Romieu-Mourez, R., Landesman-Bollag, E., Seldin, D. C. and Sonenshein, G. E. (2005) Inducible IkappaB kinase/IkappaB kinase epsilon expression is induced by CK2 and promotes aberrant nuclear factor-kappaB activation in breast cancer cells. Cancer Res. 65, 11375-11383.
18. Chantome, A., Pance, A., Gauthier, N., Vandroux, D., Chenu, J., Solary, E., Jeannin, J. F. and Reveneau, S. (2004) Casein kinase II-mediated phosphorylation of NF-kappaB p65 subunit enhances inducible nitric-oxide synthase gene transcription in vivo. J. Biol. Chem. 279, 23953-23960.
19. Wang, D., Westerheide, S. D., Hanson, J. L. and Baldwin, A. S., Jr. (2000) Tumor necrosis factor alpha-induced phosphorylation of RelA/p65 on Ser529 is controlled by casein kinase II. J. Biol. Chem. 275, 32592-32597.
20. Buchou, T., Vernet, M., Blond, O., Jensen, H. H., Pointu, H., Olsen, B. B., Cochet, C., Issinger, O. G. and Boldyreff, B. (2003) Disruption of the regulatory beta subunit of protein kinase CK2 in mice leads to a cell-autonomous defect and early embryonic lethality. Mol. Cell. Biol. 23, 908-915.
21. Canton, D. A. and Litchfield, D. W. (2006) The shape of things to come: an emerging role for protein kinase CK2 in the regulation of cell morphology and the cytoskeleton. Cell Signal. 18, 267-275.
22. Blond, O., Jensen, H. H., Buchou, T., Cochet, C., Issinger, O.-G. and Boldyreff, B. (2005) Knocking out the regulatory beta subunit of protein kinase CK2 in mice: Gene dosage effects in ES cells and embryos. Mol. Cell. Biochem. 274, 31-37.
23. Dominguez, I., Mizuno, J., Wu, H., Song, D. H., Symes, K. and Seldin, D. C. (2004) Protein kinase CK2 is required for dorsal axis formation in Xenopus embryos. Dev. Biol. 274, 110-124.
24. Hammerlein, A., Weiske, J. and Huber, O. (2005) A second protein kinase CK1-mediated step negatively regulates Wnt signalling by disrupting the lymphocyte enhancer factor-1/beta-catenin complex. Cell. Mol. Life Sci. 62, 606-618.
25. Gao, Y. and Wang, H. Y. (2006) Casein kinase 2 is activated and essential for wnt/beta-catenin signaling. J. Biol. Chem. 281, 18394-18400.
26. Wang, S. and Jones, K. A. (2006) CK2 controls the recruitment of Wnt regulators to target genes in vivo. Curr. Biol. 16, 2239-2244.
27. Tapia, J. C., Torres, V. A., Rodriguez, D. A., Leyton, L. and Quest, A. F. (2006) Casein kinase 2 (CK2) increases survivin expression via enhanced beta-catenin-T cell factor/lymphoid enhancer binding factor-dependent transcription. Proc. Natl. Acad. Sci. USA 103, 15079-15084.
28. Song, D. H., Sussman, D. J. and Seldin, D. C. (2000) Endogenous protein kinase CK2 participates in Wnt signaling in mammary epithelial cells. J. Biol. Chem. 275, 23790-23797.
29. Homma, M. K., Li, D., Krebs, E. G., Yuasa, Y. and Homma, Y. (2002) Association and regulation of casein kinase 2 activity by adenomatous polyposis coli protein. Proc. Natl. Acad. Sci. USA 99, 5959-5964.
30. Miravet, S., Piedra, J., Miro, F., Itarte, E., Garcia de Herreros, A. and Dunach, M. (2002) The transcriptional factor Tcf-4 contains different binding sites for beta-catenin and plakoglobin. J. Biol. Chem. 277, 1884-1891.
31. Pukrop, T., Gradl, D., Henningfeld, K. A., Knochel, W., Wedlich, D. and Kuhl, M. (2001) Identification of two regulatory elements within the high mobility group box transcription factor XTCF-4. J. Biol. Chem. 276, 8968-8978.
32. Packman, L. C., Kubota, K., Parker, J. and Gay, N. J. (1997) Casein kinase II phosphorylates Ser468 in the PEST domain of the Drosophila IkappaB homologue cactus. FEBS Lett. 400, 45-50.
33. Liu, Z. P., Galindo, R. L. and Wasserman, S. A. (1997) A role for CKII phosphorylation of the cactus PEST domain in dorsoventral patterning of the Drosophila embryo. Genes Dev. 11, 3413-3422.
34. Lin, J. M., Kilman, V. L., Keegan, K., Paddock, B., Emery-Le, M., Rosbash, M. and Allada, R. (2002) A role for casein kinase 2alpha in the Drosophila circadian clock. Nature 420, 816-820.
35. Jauch, E., Wecklein, H., Stark, F., Jauch, M. and Raabe, T. (2006) The Drosophila melanogaster DmCK2 beta transcription unit encodes for functionally non-redundant protein isoforms. Gene 4, 142-152.
36. Kuntamalla, P. P., Kunttas-Tatli, E., Karandikar, U., Bishop, C. P. and Bidwai, A. P. (2008) Drosophila protein kinase CK2 is rendered temperature-sensitive by mutations of highly conserved residues flanking the activation segment. Mol. Cell. Biochem. 323, 49-60.
37. Wilhelm, V., Rojas, P., Gatica, M., Allende, C. C. and Allende, J. E. (1995) Expression of the subunits of protein kinase CK2 during oogenesis in Xenopus laevis. Eur. J. Biochem. 232, 671-676.
38. Xu, X., Toselli, P. A., Russell, L. D. and Seldin, D. C. (1999) Globozoospermia in mice lacking the casein kinase II alpha' catalytic subunit. Nat. Genet. 23, 118-121.
39. Kalmykova, A. I., Dobritsa, A. A. and Gvozdev, V. A. (1997) The beta CK2tes gene encodes the tissue-specific regulatory subunit of casein kinase 2 in Drosophila melanogaster. Biochemistry (Mosc) 62, 455-460.
40. Nair, M., Nagamori, I., Sun, P., Mishra, D. P., Rheaume, C., Li, B., Sassone-Corsi, P. and Dai, X. (2008) Nuclear regulator Pygo2 controls spermiogenesis and histone H3 acetylation. Dev. Biol. 320, 446-455.
41. Stanford, J. S., Lieberman, S. L., Wong, V. L. and Ruderman, J. V. (2003) Regulation of the G2/M transition in oocytes of Xenopus tropicalis. Dev. Biol. 260, 438-448.
42. Lieberman, S. L. and Ruderman, J. V. (2004) CK2 beta, which inhibits Mos function, binds to a discrete domain in the N-terminus of Mos. Dev. Biol. 268, 271-279.
43. Chen, M., Li, D., Krebs, E. G. and Cooper, J. A. (1997) The casein kinase II beta subunit binds to Mos and inhibits Mos activity. Mol. Cell. Biol. 17, 1904-1912.
44. Russo, G. L., Tosto, M., Mupo, A., Castellano, I., Cuomo, A. and Tosti, E. (2004) Biochemical and functional characterization of protein kinase CK2 in ascidian Ciona intestinalis oocytes at fertilization. Cloning and sequence analysis of cDNA for alpha and beta subunits. J. Biol. Chem. 279, 33012-33023.
45. Bibby, A. C. and Litchfield, D. W. (2005) The multiple personalities of the regulatory subunit of protein kinase CK2: CK2 dependent and CK2 independent roles reveal a secret identity for CK2beta. Int. J. Biol. Sci. 1, 67-79.
46. Mulner-Lorillon, O., Cormier, P., Labbe, J. C., Doree, M., Poulhe, R., Osborne, H. and Belle, R. (1990) M-phase-specific cdc2 protein kinase phosphorylates the beta subunit of casein kinase II and increases casein kinase II activity. Eur. J. Biochem. 193, 529-534.
47. Lou, D. Y., Dominguez, I., Toselli, P., Landesman-Bollag, E., O'Brien, C. and Seldin, D. C. (2008) The alpha catalytic subunit of protein kinase CK2 is required for mouse embryonic development. Mol. Cell. Biol. 28, 131-139.
48. Kasahara, H. and Izumo, S. (1999) Identification of the in vivo casein kinase II phosphorylation site within the homeodomain of the cardiac tisue-specifying homeobox gene product Csx/Nkx2.5. Mol. Cell. Biol. 19, 526-536.
49. Eisenberg, L. M. and Eisenberg, C. A. (2006) Wnt signal transduction and the formation of the myocardium. Dev. Biol. 293, 305-315.
50. Grigoryan, T., Wend, P., Klaus, A. and Birchmeier, W. (2008)Deciphering the function of canonical Wnt signals in development and disease: conditional loss- and gain-of-function mutations of beta-catenin in mice. Genes Dev. 22, 2308-2341.
51. Riccomagno, M. M., Takada, S. and Epstein, D. J. (2005) Wnt-dependent regulation of inner ear morphogenesis is balanced by the opposing and supporting roles of Shh. Genes Dev. 19, 1612-1623.
52. Jones, N. C., Farlie, P. G., Minichiello, J. and Newgreen, D. F. (1999) Detection of an appropriate kinase activity in branchial arches I and II that coincides with peak expression of the Treacher Collins syndrome gene product, treacle. Hum. Mol. Genet. 8, 2239-2245.
53. Hamblet, N. S., Lijam, N., Ruiz-Lozano, P., Wang, J., Yang, Y., Luo, Z., Mei, L., Chien, K. R., Sussman, D. J. and Wynshaw-Boris, A. (2002) Dishevelled 2 is essential for cardiac outflow tract development, somite segmentation and neural tube closure. Development 129, 5827-5838.
54. Bryja, V. E., Schambony, A., Cajanek, L. S., Dominguez, I., Arenas, E. and Schulte, G. (2008) beta-Arrestin and casein kinase 1/2 define distinct branches of non-canonical WNT signalling pathways. EMBO Rep. 9, 1244-1250.
55. Meggio, F. and Pinna, L. A. (2003) One-thousand-and-one substrates of protein kinase CK2? FASEB J. 17, 349-368.
56. Seldin, D. C. and Leder, P. (1995) Casein kinase II alpha transgene-induced murine lymphoma: relation to theileriosis in cattle [see comments]. Science 267, 894-897.
57. Kelliher, M. A., Seldin, D. C. and Leder, P. (1996) Tal-1 induces T cell acute lymphoblastic leukemia accelerated by casein kinase IIa. EMBO J. 15 5160-5166.
58. Landesman-Bollag, E., Channavajhala, P. L., Cardiff, R. D. and Seldin, D. C. (1998) p53 deficiency and misexpression of protein kinase CK2alpha collaborate in the development of thymic lymphomas in mice. Oncogene 16, 2965-2974.
59. Landesman-Bollag, E., Romieu-Mourez, R., Song, D. H., Sonenshein, G. E., Cardiff, R. D. and Seldin, D. C. (2001) Protein kinase CK2 in mammary gland tumorigenesis. Oncogene 20, 3247-3257.
60. Currier, N., Solomon, S. E., Demicco, E. G., Chang, D. L., Farago, M., Ying, H., Dominguez, I., Sonenshein, G. E., Cardiff, R. D., Xiao, Z. X., Sherr, D. H. and Seldin, D. C. (2005) Oncogenic signaling pathways activated in DMBA-induced mouse mammary tumors. Toxicol. Pathol. 33, 726-737.
61. Yde, C. W., Frogne, T., Lykkesfeldt, A. E., Fichtner, I., Issinger, O. G. and Stenvang, J. (2007) Induction of cell death in antiestrogen resistant human breast cancer cells by the protein kinase CK2 inhibitor DMAT. Cancer Lett. 256, 229-237.
62. Huang, W. S., Wang, J. P., Wang, T., Fang, J. Y., Lan, P. and Ma, J. P. (2007) ShRNA-mediated gene silencing of beta-catenin inhibits growth of human colon cancer cells. World J. Gastroenterol. 13, 6581-6587.
63. Pu, P., Zhang, Z., Kang, C., Jiang, R., Jia, Z., Wang, G. and Jiang, H. (2008) Downregulation of Wnt2 and beta-catenin by siRNA suppresses malignant glioma cell growth. Cancer Gene Ther. 16, 351-361.
64. Apte, U., Zeng, G., Thompson, M. D., Muller, P., Micsenyi, A., Cieply, B., Kaestner, K. H. and Monga, S. P. (2007) beta-Catenin is critical for early postnatal liver growth. Am. J. Physiol. Gastrointest. Liver Physiol. 292, G1578-1585.
65. Tapia, M. A., Gonzalez-Navarrete, I., Dalmases, A., Bosch, M., Rodriguez-Fanjul, V., Rolfe, M., Ross, J. S., Mezquita, J., Mezquita, C., Bachs, O. et al. (2007) Inhibition of the canonical IKK/NF kappa B pathway sensitizes human cancer cells to doxorubicin. Cell Cycle 6, 2284-2292.
66. Iwanaga, R., Ozono, E., Fujisawa, J., Ikeda, M. A., Okamura, N., Huang, Y. and Ohtani, K. (2008) Activation of the cyclin D2 and cdk6 genes through NF-kappaB is critical for cell-cycle progression induced by HTLV-ITax. Oncogene 27, 5635-5642.